R&D Scope for action: How the life sciences industry can make pr... With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face